Skip to main navigation

About
Focus
Pipeline
Patients
Investors
Careers

About
Focus
Pipeline
Patients
Investors
Careers

News Releases

Year

May 16, 2023

PDF Version

X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market

May 4, 2023

PDF Version

X4 Pharmaceuticals Reports First-Quarter 2023 Financial Results and Provides Corporate Update

April 26, 2023

PDF Version

X4 Pharmaceuticals to Report First-Quarter 2023 Financial Results and Host a Conference Call and Webcast on May 4, 2023

April 12, 2023

PDF Version

X4 Pharmaceuticals Announces Late-Breaking Abstract of WHIM Phase 3 Clinical Data Accepted for Oral Presentation at the 2023 Annual Meeting of the Clinical Immunology Society (CIS)

April 4, 2023

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 21, 2023

PDF Version

X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

March 7, 2023

PDF Version

X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year 2022 Financial Results and Host a Conference Call and Webcast on March 21, 2023

March 2, 2023

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Displaying 21 - 28 of 28

quick links

Quick Links

About
Patients
Investors
Careers

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

X4 Pharmaceuticals (Austria) GmbH
Helmut-Qualtinger-Gasse 2
A-103 Vienna, Austria Phone: +43.1.395078300

© 2023 X4 Pharmaceuticals, Inc. All rights reserved.

Live - Footer

Terms of Use | Privacy Policy